A further note on chlorpromazine: Maze reactions

"Repeated administrations of the Maze Test to patients receiving chlorpromazine, in comparison with a control group, reveal a continued deficit of about two years. The decline in maze scores is comparable to that shown by patients who have undergone lobotomy."

Saved in:
Bibliographic Details
Published in:Journal of Consulting Psychology 1957-08, Vol.21 (4), p.297-299
Main Authors: Porteus, S. D, Barclay, John E
Format: Article
Language:English
Subjects:
Chlorpromazine
Chlorpromazine - pharmacology
Drug Therapy
Human
Humans
Learning
Mazes
Old Medline
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-a363t-def2487236f1d8b1c45beb0e966ec587ec0af1a9aaaeadd9f39fe186af2ebf683
cites
container_end_page 299
container_issue 4
container_start_page 297
container_title Journal of Consulting Psychology
container_volume 21
creator Porteus, S. D
Barclay, John E
description "Repeated administrations of the Maze Test to patients receiving chlorpromazine, in comparison with a control group, reveal a continued deficit of about two years. The decline in maze scores is comparable to that shown by patients who have undergone lobotomy."
doi_str_mv 10.1037/h0047254
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1290387928</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>614337355</sourcerecordid><originalsourceid>FETCH-LOGICAL-a363t-def2487236f1d8b1c45beb0e966ec587ec0af1a9aaaeadd9f39fe186af2ebf683</originalsourceid><addsrcrecordid>eNp10EtLxDAUBeAgijM-wF8gRUXcVJMmzcOdDL5AcaPrcJveMB06bU3axcyvtzIjguDqbj7OPRxCThi9ZpSrmzmlQmW52CFTZoRMmdZql0wpNXmqtWETchDjglJOtaD7ZMK4kJwpPSX0LvFD6OcYkqbtMWmbxM3rNnShXcK6avA2eYU1JgHB9VXbxCOy56GOeLy9h-Tj4f599pS-vD0-z-5eUuCS92mJPhNaZVx6VuqCOZEXWFA0UqLLtUJHwTMwAIBQlsZz45FpCT7DwkvND8nlJnds8jlg7O2yig7rGhpsh2g1M4bnQozw7A9ctENoxm5WMsG54nk-ovP_EMsM5VqZ7Pvn1Ua50MYY0NsuVEsIK8uo_R7a_gw90tNt4FAssfyF22VHcLEB0IHt4spB6CtXY7TOdTZjVtjMKP4FumCDHw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>614337355</pqid></control><display><type>article</type><title>A further note on chlorpromazine: Maze reactions</title><source>PsycARTICLES (EBSCO)</source><creator>Porteus, S. D ; Barclay, John E</creator><creatorcontrib>Porteus, S. D ; Barclay, John E</creatorcontrib><description>"Repeated administrations of the Maze Test to patients receiving chlorpromazine, in comparison with a control group, reveal a continued deficit of about two years. The decline in maze scores is comparable to that shown by patients who have undergone lobotomy."</description><identifier>ISSN: 0095-8891</identifier><identifier>ISSN: 0022-006X</identifier><identifier>EISSN: 1946-1887</identifier><identifier>EISSN: 1939-2117</identifier><identifier>DOI: 10.1037/h0047254</identifier><identifier>PMID: 13463178</identifier><language>eng</language><publisher>United States: American Psychological Association</publisher><subject>Chlorpromazine ; Chlorpromazine - pharmacology ; Drug Therapy ; Human ; Humans ; Learning ; Mazes ; Old Medline</subject><ispartof>Journal of Consulting Psychology, 1957-08, Vol.21 (4), p.297-299</ispartof><rights>1957 American Psychological Association</rights><rights>1957, American Psychological Association</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a363t-def2487236f1d8b1c45beb0e966ec587ec0af1a9aaaeadd9f39fe186af2ebf683</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/13463178$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Porteus, S. D</creatorcontrib><creatorcontrib>Barclay, John E</creatorcontrib><title>A further note on chlorpromazine: Maze reactions</title><title>Journal of Consulting Psychology</title><addtitle>J Consult Psychol</addtitle><description>"Repeated administrations of the Maze Test to patients receiving chlorpromazine, in comparison with a control group, reveal a continued deficit of about two years. The decline in maze scores is comparable to that shown by patients who have undergone lobotomy."</description><subject>Chlorpromazine</subject><subject>Chlorpromazine - pharmacology</subject><subject>Drug Therapy</subject><subject>Human</subject><subject>Humans</subject><subject>Learning</subject><subject>Mazes</subject><subject>Old Medline</subject><issn>0095-8891</issn><issn>0022-006X</issn><issn>1946-1887</issn><issn>1939-2117</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1957</creationdate><recordtype>article</recordtype><recordid>eNp10EtLxDAUBeAgijM-wF8gRUXcVJMmzcOdDL5AcaPrcJveMB06bU3axcyvtzIjguDqbj7OPRxCThi9ZpSrmzmlQmW52CFTZoRMmdZql0wpNXmqtWETchDjglJOtaD7ZMK4kJwpPSX0LvFD6OcYkqbtMWmbxM3rNnShXcK6avA2eYU1JgHB9VXbxCOy56GOeLy9h-Tj4f599pS-vD0-z-5eUuCS92mJPhNaZVx6VuqCOZEXWFA0UqLLtUJHwTMwAIBQlsZz45FpCT7DwkvND8nlJnds8jlg7O2yig7rGhpsh2g1M4bnQozw7A9ctENoxm5WMsG54nk-ovP_EMsM5VqZ7Pvn1Ua50MYY0NsuVEsIK8uo_R7a_gw90tNt4FAssfyF22VHcLEB0IHt4spB6CtXY7TOdTZjVtjMKP4FumCDHw</recordid><startdate>195708</startdate><enddate>195708</enddate><creator>Porteus, S. D</creator><creator>Barclay, John E</creator><general>American Psychological Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>EOLOZ</scope><scope>FKUCP</scope><scope>IOIBA</scope><scope>K30</scope><scope>PAAUG</scope><scope>PAWHS</scope><scope>PAWZZ</scope><scope>PAXOH</scope><scope>PBHAV</scope><scope>PBQSW</scope><scope>PBYQZ</scope><scope>PCIWU</scope><scope>PCMID</scope><scope>PCZJX</scope><scope>PDGRG</scope><scope>PDWWI</scope><scope>PETMR</scope><scope>PFVGT</scope><scope>PGXDX</scope><scope>PIHIL</scope><scope>PISVA</scope><scope>PJCTQ</scope><scope>PJTMS</scope><scope>PLCHJ</scope><scope>PMHAD</scope><scope>PNQDJ</scope><scope>POUND</scope><scope>PPLAD</scope><scope>PQAPC</scope><scope>PQCAN</scope><scope>PQCMW</scope><scope>PQEME</scope><scope>PQHKH</scope><scope>PQMID</scope><scope>PQNCT</scope><scope>PQNET</scope><scope>PQSCT</scope><scope>PQSET</scope><scope>PSVJG</scope><scope>PVMQY</scope><scope>PZGFC</scope><scope>7RZ</scope><scope>PSYQQ</scope><scope>7X8</scope></search><sort><creationdate>195708</creationdate><title>A further note on chlorpromazine: Maze reactions</title><author>Porteus, S. D ; Barclay, John E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a363t-def2487236f1d8b1c45beb0e966ec587ec0af1a9aaaeadd9f39fe186af2ebf683</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1957</creationdate><topic>Chlorpromazine</topic><topic>Chlorpromazine - pharmacology</topic><topic>Drug Therapy</topic><topic>Human</topic><topic>Humans</topic><topic>Learning</topic><topic>Mazes</topic><topic>Old Medline</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Porteus, S. D</creatorcontrib><creatorcontrib>Barclay, John E</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Periodicals Index Online Segment 01</collection><collection>Periodicals Index Online Segment 04</collection><collection>Periodicals Index Online Segment 29</collection><collection>Periodicals Index Online</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - West</collection><collection>Primary Sources Access (Plan D) - International</collection><collection>Primary Sources Access &amp; Build (Plan A) - MEA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Midwest</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Northeast</collection><collection>Primary Sources Access (Plan D) - Southeast</collection><collection>Primary Sources Access (Plan D) - North Central</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Southeast</collection><collection>Primary Sources Access (Plan D) - South Central</collection><collection>Primary Sources Access &amp; Build (Plan A) - UK / I</collection><collection>Primary Sources Access (Plan D) - Canada</collection><collection>Primary Sources Access (Plan D) - EMEALA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - North Central</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - South Central</collection><collection>Primary Sources Access &amp; Build (Plan A) - International</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - International</collection><collection>Primary Sources Access (Plan D) - West</collection><collection>Periodicals Index Online Segments 1-50</collection><collection>Primary Sources Access (Plan D) - APAC</collection><collection>Primary Sources Access (Plan D) - Midwest</collection><collection>Primary Sources Access (Plan D) - MEA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Canada</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - UK / I</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - EMEALA</collection><collection>Primary Sources Access &amp; Build (Plan A) - APAC</collection><collection>Primary Sources Access &amp; Build (Plan A) - Canada</collection><collection>Primary Sources Access &amp; Build (Plan A) - West</collection><collection>Primary Sources Access &amp; Build (Plan A) - EMEALA</collection><collection>Primary Sources Access (Plan D) - Northeast</collection><collection>Primary Sources Access &amp; Build (Plan A) - Midwest</collection><collection>Primary Sources Access &amp; Build (Plan A) - North Central</collection><collection>Primary Sources Access &amp; Build (Plan A) - Northeast</collection><collection>Primary Sources Access &amp; Build (Plan A) - South Central</collection><collection>Primary Sources Access &amp; Build (Plan A) - Southeast</collection><collection>Primary Sources Access (Plan D) - UK / I</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - APAC</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - MEA</collection><collection>PsycArticles (via ProQuest)</collection><collection>ProQuest One Psychology</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of Consulting Psychology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Porteus, S. D</au><au>Barclay, John E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A further note on chlorpromazine: Maze reactions</atitle><jtitle>Journal of Consulting Psychology</jtitle><addtitle>J Consult Psychol</addtitle><date>1957-08</date><risdate>1957</risdate><volume>21</volume><issue>4</issue><spage>297</spage><epage>299</epage><pages>297-299</pages><issn>0095-8891</issn><issn>0022-006X</issn><eissn>1946-1887</eissn><eissn>1939-2117</eissn><abstract>"Repeated administrations of the Maze Test to patients receiving chlorpromazine, in comparison with a control group, reveal a continued deficit of about two years. The decline in maze scores is comparable to that shown by patients who have undergone lobotomy."</abstract><cop>United States</cop><pub>American Psychological Association</pub><pmid>13463178</pmid><doi>10.1037/h0047254</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0095-8891
ispartof Journal of Consulting Psychology, 1957-08, Vol.21 (4), p.297-299
issn 0095-8891
0022-006X
1946-1887
1939-2117
language eng
recordid cdi_proquest_journals_1290387928
source PsycARTICLES (EBSCO)
subjects Chlorpromazine
Chlorpromazine - pharmacology
Drug Therapy
Human
Humans
Learning
Mazes
Old Medline
title A further note on chlorpromazine: Maze reactions
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T20%3A57%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20further%20note%20on%20chlorpromazine:%20Maze%20reactions&rft.jtitle=Journal%20of%20Consulting%20Psychology&rft.au=Porteus,%20S.%20D&rft.date=1957-08&rft.volume=21&rft.issue=4&rft.spage=297&rft.epage=299&rft.pages=297-299&rft.issn=0095-8891&rft.eissn=1946-1887&rft_id=info:doi/10.1037/h0047254&rft_dat=%3Cproquest_cross%3E614337355%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a363t-def2487236f1d8b1c45beb0e966ec587ec0af1a9aaaeadd9f39fe186af2ebf683%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=614337355&rft_id=info:pmid/13463178&rfr_iscdi=true